221 related articles for article (PubMed ID: 38590988)
1. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
Besola L; Gregori D; Fiocco A; Colli A
Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
[TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
[TBL] [Abstract][Full Text] [Related]
3. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy".
Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L
Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
Jackson LR; Jackson KP; Thomas KL
Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis.
Zhou Q; Liu X; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
Thromb Res; 2024 Jan; 233():88-98. PubMed ID: 38035647
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
10. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion.
Carvalho PEP; Gewehr DM; Miyawaki IA; Nogueira A; Felix N; Garot P; Darmon A; Mazzone P; Preda A; Nascimento BR; Kubrusly LF; Cardoso R
J Am Coll Cardiol; 2023 Oct; 82(18):1765-1773. PubMed ID: 37611779
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study).
Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X
J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous left atrial appendage occlusion.
Mohammed M; Ranka S; Reddy M
Curr Opin Cardiol; 2021 Jan; 36(1):36-43. PubMed ID: 33264172
[TBL] [Abstract][Full Text] [Related]
13. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
[TBL] [Abstract][Full Text] [Related]
14. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data.
Litwinowicz R; Filip G; Sobczyk D; Lakkireddy D; Vuddanda VLK; Bartuś M; Kapelak B; Bartuś K
Postepy Kardiol Interwencyjnej; 2020 Mar; 16(1):89-96. PubMed ID: 32368241
[TBL] [Abstract][Full Text] [Related]
16. Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation.
Branzoli S; Marini M; Guarracini F; Pederzolli C; Pomarolli C; D'Onghia G; Centonze M; Fantinel M; Corsini F; Bonmassari R; Graffigna A; La Meir M
J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2187-2191. PubMed ID: 32495408
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes.
Melillo F; Leo G; Parlati ALM; Gaspardone C; Bellini B; Della Bella P; Montorfano M; Mazzone P; Nemola G; Cozzani G; Stella S; Ancona F; Ingallina G; Salerno A; Cera M; Agricola E; Margonato A; Godino C
Int J Cardiol; 2023 Oct; 389():131188. PubMed ID: 37453454
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real-world experience from a tertiary care hospital.
Margonato D; Preda A; Ingallina G; Rizza V; Fierro N; Radinovic A; Ancona F; Patti G; Agricola E; Bella PD; Mazzone P
J Arrhythm; 2023 Jun; 39(3):395-404. PubMed ID: 37324751
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
Labori F; Persson J; Bonander C; Jood K; Svensson M
Eur Heart J; 2022 Mar; 43(13):1348-1356. PubMed ID: 34919652
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
